{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:5810"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:5810","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"The synthesis of biologically active heterocycles: development of novel imaging agents for the translocator protein (18 kDa) and poly(ADP-ribose)polymerase 1","abstract":"The Translocator Protein (18 kDa) (TSPO) resides mainly in microglia and is upregulated in response to neuronal injury and inflammation, rendering it an interesting target for imaging focal neuroinflammation in a range of diseases. A library of TSPO ligands based on PK11195 with positions suitable for [11C]-, [18F]- and [123I]-labelling was prepared using three synthetic approaches. Implementation of a physicochemical study enabled selection of compounds most likely to be brain penetrant, and biological evaluation identified those with high binding affinities for the TSPO. From this, a lead candidate (compound 170) was identified. Radiofluorination and in vitro autoradiography revealed the ability of this compound to image tumour tissue in a mouse model of glioblastoma. Poly(ADP-ribose) polymerase-1 (PARP-1) is an enzyme involved in the repair of DNA strand breaks, and widely regarded as a therapeutic target for cancer treatment. Many inhibitors of PARP-1 activity exist, e.g. olaparib. A programme of research focussing on the preparation of a potential PET imaging agent for measurement of PARP-1 activity, based on olaparib, was initiated. An expeditious seven step synthetic route was used to prepare a small library of compounds. Preliminary cell-free biological screening of these compounds indicated PARP-1 inhibitory potencies in the low nanomolar range demonstrating potential leads for development of a PET imaging agent, e.g. compound 223. Extracts of Carduus crispus linn., traditionally used in Chinese folk medicine, yield a family of isoquinoline alkaloid natural products (Crispine A–E). Upon commencement of this project no reported synthesis of Crispine C existed in the literature. As such, a facile route utilising a key Pictet-Gams modification of the Bischler-Napieralski reaction for isoquinoline core formation was developed, enabling the first total synthesis of Crispine C to be achieved in seven steps and with an overall product yield of 25%.","abstract_html":"The Translocator Protein (18 kDa) (TSPO) resides mainly in microglia and is upregulated in response to neuronal injury and inflammation, rendering it an interesting target for imaging focal neuroinflammation in a range of diseases. A library of TSPO ligands based on PK11195 with positions suitable for [11C]-, [18F]- and [123I]-labelling was prepared using three synthetic approaches. Implementation of a physicochemical study enabled selection of compounds most likely to be brain penetrant, and biological evaluation identified those with high binding affinities for the TSPO. From this, a lead candidate (compound 170) was identified. Radiofluorination and in vitro autoradiography revealed the ability of this compound to image tumour tissue in a mouse model of glioblastoma. Poly(ADP-ribose) polymerase-1 (PARP-1) is an enzyme involved in the repair of DNA strand breaks, and widely regarded as a therapeutic target for cancer treatment. Many inhibitors of PARP-1 activity exist, e.g. olaparib. A programme of research focussing on the preparation of a potential PET imaging agent for measurement of PARP-1 activity, based on olaparib, was initiated. An expeditious seven step synthetic route was used to prepare a small library of compounds. Preliminary cell-free biological screening of these compounds indicated PARP-1 inhibitory potencies in the low nanomolar range demonstrating potential leads for development of a PET imaging agent, e.g. compound 223. Extracts of Carduus crispus linn., traditionally used in Chinese folk medicine, yield a family of isoquinoline alkaloid natural products (Crispine A–E). Upon commencement of this project no reported synthesis of Crispine C existed in the literature. As such, a facile route utilising a key Pictet-Gams modification of the Bischler-Napieralski reaction for isoquinoline core formation was developed, enabling the first total synthesis of Crispine C to be achieved in seven steps and with an overall product yield of 25%.","abstract_has_math":false,"creators":["Blair, Adele"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014","date_published":"2014","updated_at":"2026-11-19T08:24:00Z","subjects":["QD Chemistry"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://theses.gla.ac.uk/5810/7/2014Blairphd.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A5810","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Blair, Adele"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014"]},{"key":"dc:date.issued","label":"Date","values":["2014"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/5810/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/900445391"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QD Chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/5810/7/2014Blairphd.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The Translocator Protein (18 kDa) (TSPO) resides mainly in microglia and is upregulated in response to neuronal injury and inflammation, rendering it an interesting target for imaging focal neuroinflammation in a range of diseases. A library of TSPO ligands based on PK11195 with positions suitable for [11C]-, [18F]- and [123I]-labelling was prepared using three synthetic approaches. Implementation of a physicochemical study enabled selection of compounds most likely to be brain penetrant, and biological evaluation identified those with high binding affinities for the TSPO. From this, a lead candidate (compound 170) was identified. Radiofluorination and in vitro autoradiography revealed the ability of this compound to image tumour tissue in a mouse model of glioblastoma. Poly(ADP-ribose) polymerase-1 (PARP-1) is an enzyme involved in the repair of DNA strand breaks, and widely regarded as a therapeutic target for cancer treatment. Many inhibitors of PARP-1 activity exist, e.g. olaparib. A programme of research focussing on the preparation of a potential PET imaging agent for measurement of PARP-1 activity, based on olaparib, was initiated. An expeditious seven step synthetic route was used to prepare a small library of compounds. Preliminary cell-free biological screening of these compounds indicated PARP-1 inhibitory potencies in the low nanomolar range demonstrating potential leads for development of a PET imaging agent, e.g. compound 223. Extracts of Carduus crispus linn., traditionally used in Chinese folk medicine, yield a family of isoquinoline alkaloid natural products (Crispine A–E). Upon commencement of this project no reported synthesis of Crispine C existed in the literature. As such, a facile route utilising a key Pictet-Gams modification of the Bischler-Napieralski reaction for isoquinoline core formation was developed, enabling the first total synthesis of Crispine C to be achieved in seven steps and with an overall product yield of 25%."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["The synthesis of biologically active heterocycles: development of novel imaging agents for the translocator protein (18 kDa) and poly(ADP-ribose)polymerase 1"]}]}],"canonical_facts":{"dc:creator":["Blair, Adele"],"dc:date":["2014"],"dc:date.issued":["2014"],"dc:description.abstract":["The Translocator Protein (18 kDa) (TSPO) resides mainly in microglia and is upregulated in response to neuronal injury and inflammation, rendering it an interesting target for imaging focal neuroinflammation in a range of diseases. A library of TSPO ligands based on PK11195 with positions suitable for [11C]-, [18F]- and [123I]-labelling was prepared using three synthetic approaches. Implementation of a physicochemical study enabled selection of compounds most likely to be brain penetrant, and biological evaluation identified those with high binding affinities for the TSPO. From this, a lead candidate (compound 170) was identified. Radiofluorination and in vitro autoradiography revealed the ability of this compound to image tumour tissue in a mouse model of glioblastoma. Poly(ADP-ribose) polymerase-1 (PARP-1) is an enzyme involved in the repair of DNA strand breaks, and widely regarded as a therapeutic target for cancer treatment. Many inhibitors of PARP-1 activity exist, e.g. olaparib. A programme of research focussing on the preparation of a potential PET imaging agent for measurement of PARP-1 activity, based on olaparib, was initiated. An expeditious seven step synthetic route was used to prepare a small library of compounds. Preliminary cell-free biological screening of these compounds indicated PARP-1 inhibitory potencies in the low nanomolar range demonstrating potential leads for development of a PET imaging agent, e.g. compound 223. Extracts of Carduus crispus linn., traditionally used in Chinese folk medicine, yield a family of isoquinoline alkaloid natural products (Crispine A–E). Upon commencement of this project no reported synthesis of Crispine C existed in the literature. As such, a facile route utilising a key Pictet-Gams modification of the Bischler-Napieralski reaction for isoquinoline core formation was developed, enabling the first total synthesis of Crispine C to be achieved in seven steps and with an overall product yield of 25%."],"dc:format":["pdf"],"dc:identifier.uri":["https://theses.gla.ac.uk/5810/7/2014Blairphd.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/5810/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/900445391"],"dc:subject":["QD Chemistry"],"dcterms:accessrights":["public"],"dc:title":["The synthesis of biologically active heterocycles: development of novel imaging agents for the translocator protein (18 kDa) and poly(ADP-ribose)polymerase 1"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:24:00Z"}